- Home
- PLUR vs LVTX Comparison
PLUR vs LVTX Comparison
Compare PLUR & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- LVTX
- Stock Information
- Founded
- PLUR 2001
- LVTX 2016
- Country
- PLUR Israel
- LVTX Netherlands
- Employees
- PLUR N/A
- LVTX N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- PLUR Health Care
- LVTX Health Care
- Exchange
- PLUR Nasdaq
- LVTX Nasdaq
- Market Cap
- PLUR 41.9M
- LVTX 33.9M
- IPO Year
- PLUR N/A
- LVTX 2021
- Fundamental
- Price
- PLUR $5.88
- LVTX N/A
- Analyst Decision
- PLUR Strong Buy
- LVTX Hold
- Analyst Count
- PLUR 1
- LVTX 3
- Target Price
- PLUR $12.00
- LVTX $1.75
- AVG Volume (30 Days)
- PLUR 62.9K
- LVTX 12.3K
- Earning Date
- PLUR 05-13-2025
- LVTX 08-19-2025
- Dividend Yield
- PLUR N/A
- LVTX N/A
- EPS Growth
- PLUR N/A
- LVTX N/A
- EPS
- PLUR N/A
- LVTX N/A
- Revenue
- PLUR $1,034,000.00
- LVTX $4,990,000.00
- Revenue This Year
- PLUR $472.39
- LVTX N/A
- Revenue Next Year
- PLUR $254.29
- LVTX N/A
- P/E Ratio
- PLUR N/A
- LVTX N/A
- Revenue Growth
- PLUR 203.23
- LVTX N/A
- 52 Week Low
- PLUR $3.33
- LVTX $0.85
- 52 Week High
- PLUR $7.13
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- PLUR 66.26
- LVTX 52.45
- Support Level
- PLUR $4.61
- LVTX $1.27
- Resistance Level
- PLUR $5.40
- LVTX $1.38
- Average True Range (ATR)
- PLUR 0.55
- LVTX 0.04
- MACD
- PLUR 0.13
- LVTX -0.00
- Stochastic Oscillator
- PLUR 91.46
- LVTX 44.64
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.